Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

TX2® Low Profile TAA Endovascular Graft (TX2® LP)

Expanded access is currently available for this treatment.
Verified August 2014 by Cook
Information provided by (Responsible Party):
Cook Identifier:
First received: June 22, 2010
Last updated: August 20, 2014
Last verified: August 2014

The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vessel structure suitable for repair.

Condition Intervention
Aortic Aneurysm
Penetrating Ulcer
Vascular Disease
Device: Zenith® TX2® Low Profile TAA Endovascular Graft (Thoracic Aortic Aneurysm)

Study Type: Expanded Access     What is Expanded Access?
Official Title: Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study

Resource links provided by NLM:

Further study details as provided by Cook:

Study Start Date: October 2010
Estimated Study Completion Date: December 2019
Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Zenith® TX2® Low Profile TAA Endovascular Graft (Thoracic Aortic Aneurysm)
    Endovascular treatment of patients with aneurysms/ulcers of the descending thoracic aorta having morphology suitable for endovascular repair
    Other Name: TEVAR

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Descending thoracic aneurysm with diameter ≥ 5.0 cm
  • Descending thoracic aneurysm with a history of growth ≥ 0.5 cm per year
  • Descending thoracic degenerative or atherosclerotic ulcer ≥ 10 mm in depth and 20 mm in diameter

Exclusion Criteria:

  • Less than 18 years of age
  • Life expectancy less than 2 years
  • Pregnant or breastfeeding or planning on becoming pregnant within 60 months
  • Unwilling to comply with the follow-up schedule
  • Inability or refusal to give informed consent
  • Less than 30 days beyond primary endpoint for other investigative drug or device study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01151020

Contact: Jennifer Gilmore 765-463-7537

  Hide Study Locations
United States, California
Kaiser Permanente
San Francisco, California, United States, 94115
Contact: Osvaldo Yano, MD    415-833-3383   
United States, District of Columbia
Washington Hospital Center
Washington, District of Columbia, United States, 20010
Contact: Federick Beavers, MD    202-877-5975   
United States, Florida
University of South Florida
Tampa, Florida, United States, 33606
Contact: Stephenie Yachanyk, RN    813-259-0921   
United States, Georgia
Emory University
Atlanta, Georgia, United States, 30322
Contact: Ravi Veeraswamy, MD    404-778-4465   
United States, Indiana
Indiana Heart Hospital
Indianapolis, Indiana, United States, 46250
Contact: Gregory Dedinsky, MD    317-621-8500   
Methodist Hospital of Indiana
Indianapolis, Indiana, United States, 46202
Contact: Joel Corvera, MD    317-962-5888   
United States, Michigan
University of Michigan
Ann Arbor, Michigan, United States, 48109
Contact: Himanshu Patel, MD    734-936-4478   
United States, Minnesota
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905
Contact: Gustavo Oderich, MD    507-225-7208   
United States, Missouri
Barnes-Jewish Hospital
St. Louis, Missouri, United States, 63110
Contact: Patrick Geraghty, MD    314-362-6490   
United States, New Hampshire
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Contact: Mark Fillinger, MD    603-650-8677   
United States, New Jersey
Cooper University Hospital
Camden, New Jersey, United States, 08103
Contact: Francis Caputo, MD    856-342-3113   
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Contact: Susan Mathus, BSN, RN, CCRC    551-996-5722   
United States, New York
Mount Sinai Hospital
New York, New York, United States, 10029
Contact: Sharif Ellozy, MD    212-241-3738   
New York University Hospital
New York, New York, United States, 10016
Contact: Neal Cayne, MD    212-263-7311   
United States, North Carolina
University of North Carolina
Chapel Hill, North Carolina, United States, 27599
Contact: Mark Farber, MD    919-966-3391   
Duke University Medical Center
Durham, North Carolina, United States, 27710
Contact: Chad Hughes, MD    919-668-0903   
United States, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
Contact: Tara Mastracci, MD    216-445-1338   
Ohio State University
Columbus, Ohio, United States, 43210
Contact: Jean Starr, MD    614-293-8536   
United States, Pennsylvania
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Contact: Grace Wang, MD    215-614-0308   
United States, Tennessee
Tennessee Baptist Memorial Hospital
Memphis, Tennessee, United States, 38120
Contact: Suzanne Burgar, PA-C, CCRC    901-747-1247   
United States, Virginia
Inova Fairfax Hospital
Falls Church, Virginia, United States, 22042
Contact: Dipankar Mukherjee, MD    703-280-5858   
United States, Washington
Harborview Medical Center
Seattle, Washington, United States, 98104
Contact: Benjamin Starnes, MD    206-744-3370   
Morinomiya Hospital
Osaka, Japan
Contact: Masakaki Kato    81669690111   
Jikei University School of Medicine
Tokyo, Japan, 105-8461
Contact: Midori Kobayashi    817055826055   
Keio University Hospital
Tokyo, Japan, 160-8582
Contact: Hideyuki Shimizu    813-353-1211   
Sponsors and Collaborators
Principal Investigator: Karl Illig, MD University of South Florida
  More Information

Additional Information:
No publications provided

Responsible Party: Cook Identifier: NCT01151020     History of Changes
Other Study ID Numbers: 10-001
Study First Received: June 22, 2010
Last Updated: August 20, 2014
Health Authority: United States: Food and Drug Administration

Keywords provided by Cook:
Aortic Aneurysm
Vascular Prosthesis
Vascular Disease
Blood Vessel Prosthesis Implantation

Additional relevant MeSH terms:
Aortic Aneurysm
Vascular Diseases
Aortic Diseases
Cardiovascular Diseases processed this record on November 25, 2014